Trial NCT00644878

View at ClinicalTrials.gov 
Org. Study IDs: CAMN107AUS09

Last trial update was posted on 2021-08-18

MeSH Interventions

Nilotinib

MeSH Conditions

Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Leukemia, Myeloid, Chronic-Phase Philadelphia Chromosome

Other Conditions

Chronic Myelogenous Leukemia - Chronic Phase

Stopping Reasons

Slower than expected enrollment

Limitations And Caveats

The study was terminated on 31 March 2012 due to slower than planned enrollment, resulting in a small sample size, no inferential analyses were conducted.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID